Clinical trial
A Biospecimen Collection Study to Identify the Targets of Disease-Reactive T Cells in Patients With Autoimmune Disease
NCT06587828 is registered in ClinicalTrials.gov with TScan Therapeutics, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Biospecimen Collection Study to Identify the Targets of Disease-Reactive T Cells in Patients With Autoimmune Disease
- Lead sponsor
- TScan Therapeutics, Inc.
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 3, 2023
- Completion date
- September 10, 2026
- Enrollment
- 238 (actual)
- Sites
- 11
Conditions
As the registry lists them; a condition with its own page is linked.
ankylosing spondylitis, autoimmune diseases, birdshot chorioretinitis, celiac disease, crohn's disease, multiple sclerosis, non-radiographic axial spondyloarthritis (nr-axspa), scleroderma, ulcerative colitis